Position papers

Displaying 1 - 3 of 3

GMO medicinal products / COVID-19

Adottati on 15/07/2020

Referenza:

NAT/797-EESC-2020-2020-03040

Referral:

COM(2020) 261 final 2020/0128 COD

General Rapporteur:

Renate HEINISCH

Opinjoni tal-KESE: GMO medicinal products / COVID-19

bg
es
cs
da
de
et
el
en
fr
hr
it
lv
lt
hu
mt
nl
pl
pt
ro
sk
sl
fi
sv

Support under EAFRD in response to the COVID-19 outbreak

Adottati on 10/06/2020

Referenza:

NAT/795-EESC-2020

Referral:

COM(2020) 186 final 2020/0075 COD

Rapporteur:

Arnold PUECH d'ALISSAC (Employers - GR I / France)

Opinjoni tal-KESE: Support under EAFRD in response to the COVID-19 outbreak

bg
es
cs
da
de
et
el
en
fr
ga
hr
it
lv
lt
hu
mt
nl
pl
pt
ro
sk
sl
fi
sv

COVID-19 Measures / Fisheries and aquaculture

Adottati on 05/05/2020

Referenza:

NAT/783-EESC-01726-00-01-pac-TRA

Referral:

COM(2020) 142 final 2020/0059 COD

General Rapporteur:

Gabriel SARRÓ IPARRAGUIRRE